Optimisation of Radiation Protection in the Cardiac Catheter Lab
Research type
Research Study
Full title
The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study - The REDUCE trial
IRAS ID
315967
Contact name
John Hung
Contact email
Sponsor organisation
Liverpool Heart and Chest Hospital
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Recent decades have seen major increases in x-ray guided procedures in interventional cardiology, radiology and vascular surgery. Exposure to ionising radiation is known to be an inherent risk and remains a serious and unresolved threat to the health of operators and their team. It is associated with an increased incidence of brain and blood cancers, cataracts, and recent mechanistic data indicates significantly increased DNA damage in those without leaded leg protection.
Although existing standard radiation protection measures somewhat reduces exposure, all cardiac catheter lab personnel still receive a certain dose of radiation and continue to accumulate lifetime exposure. Furthermore, leaded personal protective equipment is heavy, leads to orthopaedic complications, and detracts from operator comfort.
Novel radiation protection devices such as RAMPART may significantly reduce radiation doses to cardiac catheter lab personnel, and potentially allow the use of lighter lead, or no lead at all. In this study we aim to investigate if use of RAMPART significantly reduces radiation exposure, when compared with standard radiation protection.
Standard coronary intervention procedures will be randomised to RAMPART or standard (radiation protection), and operators and Cath lab team doses will be compared.REC name
South West - Frenchay Research Ethics Committee
REC reference
24/SW/0148
Date of REC Opinion
23 Dec 2024
REC opinion
Further Information Favourable Opinion